AzTrials
AzTrials

Cardiac RehabilitationNCT03174106

Longterm Follow-up of Cardiac Patients With an Smartphone-Application

A study testing Smartphone-Application in people with Cardiac Rehabilitation and Mobile Health, run by Oslo Metropolitan University at 2 sites in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cardiovascular disease is the leading cause of morbidity and mortality globally. Cardiac rehabilitation (CR) including exercise training are effective to reduce morbidity, mortality and risk factors such as physical fitness, cholesterol, triglycerides and blood pressure. Read more about this study

Who is it for?
Ages 40 years and older
What is being tested?
Smartphone-Application
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
113 participants
Where
2 sitesNorway
Study dates
5 Oct 2017to 24 Jun 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Finished Cardiac rehabilitation at NIMI or Feiring
  • ≥ 40 years old
  • Owner and user of a Smartphone
  • Understanding basic Norwegian or English

Who cannot join

  • Severe malignant disease that affects the patient's life to a greater extent than the heart disease
  • Musculoskeletal- changes or diseases, that affect the patient's physical capacity and quality of life more than their heart disease
  • Ischemia or arrytmia at treadmill test which gives the patient restrictions regarding exercise intensity equivalent >80% av HFmax eller BORG scale >15

Trial locations and contacts

2 sites in 1 country.

Norway2 sites
  • LHL-Feiring

    Feiring

  • NIMI

    Oslo

Other trials in Norway

About this study

Official title: Longterm Follow-up of Cardiac Patients With an Smartphone-Application -A Randomized Clinical Study

Cardiovascular disease is the leading cause of morbidity and mortality globally. Cardiac rehabilitation (CR) including exercise training are effective to reduce morbidity, mortality and risk factors such as physical fitness, cholesterol, triglycerides and blood pressure. The main goal for CR is to establish exercise training and other lifestyle changes as permanent changes in the patient's life. Many studies have shown that cardiac patients strive to maintain a heart-healthy lifestyle, one year after participating in CR. Furthermore, this leads to risk profile returning to the starting point where they got their Cardiac event. Changing a lifestyle is known to take time, and we believe that the patients need further follow-up beyond the time spent in traditional CR.

To our knowledge very few, if any, studies evaluates the use of modern technology in longterm follow-up focusing on maintaining a new lifestyle after participating in CR. The investigators would like to evaluate the effect of an dynamic application (app) with regard to physical fitness, lifestyle and quality of life (QoL), one year after CR. The investigators hypothesize that patients getting Access to a dynamic Application and tailored feedback through the application after CR will better be able to take care of physical Fitness and other lifestyle factors one year after CR, compared to patients getting usal care.

Read the detailed description

Introduction:

Smartphones are widespread and in 2015 as much as 82% of the Norwegian population were owners of a smartphone. Recommendations has been pointed out in a new report from the Norwegian Board of Technology; health service should facilitate so that patients can follow up their health from home and simultaneously receive necessary help from the health service. The Norwegian Directorate of health points in a national action plan for e-health that evidence based digital tools in combination with an increase of competence will make it possible to reach health political goals such as quality levels, patient safety and an effective use of resources.

Across diseases adherence to treatment is one of the most important modifiable factors wich decreases the treatment effect. As much as 30-50% of patients do not adhere to recommended treatment. Adherence to treatment is complex and it depends on many factors; the patient, the patient surroundings (social support, the function of the health service, availability and resources) and characteristics with the disease and the corresponding treatment. World Health Organization (WHO) points to adherence to treatment as a global challenge and supports political decisions and research interventions that will increase adherence. Furthermore, adherence is considered to be a huge challenge in treatment for lifestyle changes such as smoking cessation, diet changes, training and physical activity. A meta-analysis (n=42 000) documented that "mixed mode of delivery interventions", where traditional techniques for behavior change was combined with digital tools, proved more effective than the use of traditional techniques for behavior change alone. Another meta-analysis (n=20 000) confirms this conclusion; therapy, guidance and conversation has an increased effect when it is used together with dedicated digital tools (6).

Cardiovascular disease is the leading cause of morbidity and mortality globally. Cardiac rehabilitation (CR) including exercise training are effective to reduce morbidity, mortality and modifiable risk factors such as physical fitness, cholesterol, triglycerides and blood pressure. The main goal for CR is to establish exercise training and other lifestyle changes as permanent changes in the patient's life. Many studies have shown that cardiac patients do not reach the therapeutic goals regarding secondary prophylaxis one year after participating in CR. In other words; patients are not able to maintain the new lifestyle after CR and their risk profile goes back to base. Changing a lifestyle is known to take time, and we believe that the patients need further follow-up beyond the time spent in traditional CR.

To our knowledge very few studies, if any, evaluates the use of modern technology aiming to help the patients to maintain a new lifestyle after participating in CR. The investigators would therefore like to implement a randomized clinical trial (RCT) to evaluate the effect of the dynamic Application Vett® With regard to physical Fitness (peak oxygen uptake), one year after CR.

Method:

  • Design: The study will be a randomized clinical trial. Patients will be recruited from CR at Norwegian Institute of Sports Medicine (NIMI) and from Feiring. NIMI has an outpatient CR programme lasting for twelve weeks. Feiring has Institutional CR With two different durations at their programmes, whereas one of the programmes lasting four weeks an the other programme lasting for one week. The investigators will conduct a stratified randomization to ensure Equal number of patients from the different CR programmes into the intervention-group and the Control Group. Patients will be recruited when they finish CR.
  • Intervention-group: In addition to usal care, patients in the intervention-group will get access to the application Vett®, as well as approximately one hour of training on how to use it and register personal goals together with study-coordinator. They will for a period of approximately twelve months have access to Vett® as well as personal follow-up through the app by a specialized physiotherapist. Vett® is an app developed by professor Kari Jorunn Kværner, doctor and specialist in cognitive training, guidance and counseling. Patients will be encouraged to set a minimum of two goals with associated tasks for the follow-up periode. Tasks will be the basis for reminders which the Application gives the patient. The patient decide when and how often reminders should come. The goals and tasks will be set according to the needs of each patient (individualized). The follow-up is individualized and dynamic and targets the patient under evaluation directly. Vett® makes it possible to create and set individual goals (e.g. exercise or eating fish) with tasks and reminders, weekly evaluation of the individual goals and ask questions to the supervisor. The application also gives the opportunity to receive tailored and motivational feedback from the supervisor. The supervisor has access to an administrator interface where it is possible to monitor what the patients are registering in relation to their personal goals and tasks, as well as sending tailored and motivational feedback. In this study, the patients will receive tailored feedback based on their achievements on personal goals and tasks through e-mail. They will receive feedback every week for the first Three months, then they will receive feedback as often as they want based on the conversation when included to the study. They will also receive 1-3 motivational feedbacks/notifications every week. Any questions to the supervisor will be answered by two working days. In the event of receiving health related questions (e.g changing of medication or chest pain) the patients will be advised to contact their general practitioner (GP). One year after CR patients will be called for a check-up, including questionnaires and a cardiorespiratory Fitness test.
  • Control-Group: Patients in the control-group will receive what is current practice. In addition they will be called for a check-up, one year after entering CR, including questionnaires and a cardiorespiratory Fitness test. To day, usual care consist of advice regarding how to maintain their New lifestyle (exercise training, physical Activity and heart-healthy diet) and further follow-up by their GP.
  • Power calculation: With a significant Level of 5%, Power of 0,80 and a effect size at 0,58 (Clinical important change as 3,5 ml/kg/min i VO2peak and a Standard deviation of 6 ml/kg/min), 48 patients is needed in each Group. With an estimated drop-out of 20%, 115 patients will be recruited to this study.
  • Statistical analyzes: Both Parametric and non-Parametric analyzes will be used depending on the variables. Both intention-to-treat and per-protocol analyzes will be conducted in the effect-analyzes. T-test and variance analyzes will be used to investigate differences between Groups.

This study will provide New knowledge about the use of modern Technology with an Smartphone-Application in the follow-up of Cardiac patients. If the Application proves to be effective, this study will give clinicians a digital and evidence based tool for longterm follow-up of patients where changing lifestyle is the primary treatment.

Being tested
Smartphone-Application
Medical subject headings
Heart Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Smartphone-ApplicationDevice

    Longterm follow-up after Cardiac rehabilitation With an Smartphone-Application

Study groups in NCT03174106
Study groupRoleWhat they receive
Smartphone-ApplicationExperimentalPatients in "Smartphone-Application"-arm will get Access to the Application Vett, they will be learned how to use it. They will receive feedback based on their goals and tasks in the Application for one year, and they will also receive motivational Notifications through the Application, atleast once a week in the follow-up period. Patients in this arm will also have the possibility to send questions to their supervisor through the Application, in that case they will receive answer within two working days. In addition they will receive usual care which is described below.
Receives: Device: Smartphone-Application
Control-groupNo interventionPatients in the control-group will receive usual care consisting of general advice according to a heart-friendly lifestyle and follow-up by their general practitioner.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Maximal oxygen consumption

    Physical capacity will be evaluated With maximal oxygen consumption. We will do a cardiorespiratory Fitness test on a treadmill With a standardized ramp-protocol and Direct measurement of oxygen consumption

    Measured: Change from baseline to 12 months

Secondary outcomes (5)
  1. Change in Quality of Life

    Heart-Quality of Life (HeartQoL) will be used to assess quality of life. This is a disease specific questionnaire where you get an score between 0-3 (0 representing bad quality of life and 3 representing good quality of life). It consist of 14 question and you can get an emotional subscale and a physical subscale, aswell as a global scale.

    Measured: Change from baseline to 12 months

  2. Change in Quality of Life

    Euro Quality of life questionnaire (EQ-5D)

    Measured: Change from baseline to 12 months

  3. Change in Health Literacy

    European Health Literacy Survey questionnaire (HLS-EU-Q47)

    Measured: Change from baseline to 12 months

  4. Type D personality

    Standard assessment of Negative Affectivity, Social Inhibition, and Type D personality (DS14).

    Measured: Baseline

  5. Change in Endurance Fitness

    Time to exhaution, incline and speed at the treadmill test.

    Measured: Change from baseline to 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jun 2017
  2. Study start5 Oct 2017
  3. Primary completion24 Jun 2019
  4. Study completion24 Jun 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomization to two different arms, intervention- or control-group
Masking
Double blind
Who is masked
Care provider, Outcomes assessor
Enrolment
113 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03174106
Sponsor's protocol ID
Smartphone-application
Status last verified
Jul 2019
First submitted
19 May 2017
Last updated
22 Jul 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Lunde P, Bye A, Grimsmo J, Pripp AH, Ritschel V, Jarstad E, Nilsson BB. Effects of Individualized Follow-Up With an App Postcardiac Rehabilitation: Five-Year Follow-Up of a Randomized Controlled Trial. J Med Internet Res. 2025 Feb 13;27:e60256. doi: 10.2196/60256.

    PubMed 39946716
  • Lunde P, Bye A, Bergland A, Nilsson BB. Effects of individualized follow-up with a smartphone-application after cardiac rehabilitation: protocol of a randomized controlled trial. BMC Sports Sci Med Rehabil. 2019 Nov 21;11:34. doi: 10.1186/s13102-019-0148-2. eCollection 2019.

    PubMed 31768261

Questions about this trial

What is this clinical trial studying?

A study testing Smartphone-Application in people with Cardiac Rehabilitation and Mobile Health, run by Oslo Metropolitan University at 2 sites in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Maximal oxygen consumption (time frame: Change from baseline to 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03174106, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in